FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat bladder cancers
Disease control OngoingThis study tests a new drug called TYRA300 in people with advanced bladder cancer or other solid tumors that have a specific gene change (FGFR3). The goal is to find a safe dose and see if the drug can shrink tumors. About 310 adults whose cancer has not responded to standard tre…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New pill shows promise for tough bladder cancer before surgery
Disease control OngoingThis study tests a pill called erdafitinib in people whose bladder cancer has come back after standard treatments like BCG or chemotherapy. Only patients with a specific gene change (FGFR3 mutation) in their tumor can join. The goal is to see if the pill can shrink or eliminate t…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:13 UTC